Cochrane Abstracts
Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Monoclonal Antibody for Reducing the Risk of Respiratory Syncytial Virus Infection in Children." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440298/all/Monoclonal_antibody_for_reducing_the_risk_of_respiratory_syncytial_virus_infection_in_children.
Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440298/all/Monoclonal_antibody_for_reducing_the_risk_of_respiratory_syncytial_virus_infection_in_children. Accessed January 15, 2026.
Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440298/all/Monoclonal_antibody_for_reducing_the_risk_of_respiratory_syncytial_virus_infection_in_children
Monoclonal Antibody for Reducing the Risk of Respiratory Syncytial Virus Infection in Children [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440298/all/Monoclonal_antibody_for_reducing_the_risk_of_respiratory_syncytial_virus_infection_in_children.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children
ID - 440298
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440298/all/Monoclonal_antibody_for_reducing_the_risk_of_respiratory_syncytial_virus_infection_in_children
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
